Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DocTalk
AddedMar 22, 2024
UpdatedJun 18, 2026
DocTalk

DocTalk

Seed

DocTalk Solutions: Connecting patients with doctors through a mobile app.

HQ
Mumbai, Maharashtra, IN
Founded
2016
Overview
Compare
Fundraising
Employees
Website

DocTalk Solutions develops a mobile application that facilitates direct communication between patients and doctors. The app enables users to chat with their physicians, obtain prescriptions, and share medical reports seamlessly. This digital platform aims to streamline healthcare interactions, making it more convenient for patients to access medical services and information.

The company's innovative approach to healthcare communication has the potential to improve patient care and medical outcomes. By providing a user-friendly interface for doctor-patient interactions, DocTalk contributes to more efficient healthcare delivery and potentially reduces unnecessary in-person visits, saving time for both patients and healthcare providers.

DocTalk - Similar Companies

IM Your Doc logo

IM Your Doc

imyourdoc.com

DocBuddy logo

DocBuddy

docbuddy.com

Medici logo

Medici

HeyDoc! logo

HeyDoc!

heydoc.net

MedChat logo

MedChat

medchatapp.com

Docty logo

Docty

docty.ai

Doc.com logo

Doc.com

MDconnectME logo

MDconnectME

ConsultLink logo

ConsultLink

ahoyDoc logo

ahoyDoc

CallingDr logo

CallingDr

GetDoctor logo

GetDoctor

getdoctor.co

Medcorder logo

Medcorder

medcorder.com

medEchat logo

medEchat

medechat.com

DrAvailable logo

DrAvailable

DocTalk - Quick Facts

Who are DocTalk's competitors?

Companies similar to DocTalk include IM Your Doc, DocBuddy, Medici and HeyDoc!.

When was DocTalk founded?

DocTalk was founded in 2016.

Where is DocTalk's headquarters located?

DocTalk's headquarters is located in Mumbai, Maharashtra, IN.

When was DocTalk's last funding round?

DocTalk's most recent funding round was for $5M (USD) in November 2017.

How much has DocTalk raised to-date?

As of Nov 7, 2017, DocTalk has raised a total of $5M (USD).

How many employees does DocTalk have?

DocTalk has 75 employees as of Feb 24, 2024.

DocTalk - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Medical App
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities